Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 13;18(20):10717.
doi: 10.3390/ijerph182010717.

Acceptability of Clinical Trials on COVID-19 during Pregnancy among Pregnant Women and Healthcare Providers: A Qualitative Study

Affiliations

Acceptability of Clinical Trials on COVID-19 during Pregnancy among Pregnant Women and Healthcare Providers: A Qualitative Study

Elena Marbán-Castro et al. Int J Environ Res Public Health. .

Abstract

Participation of pregnant women in clinical trials entails challenges mainly related to concerns about the risks for fetuses. We undertook a qualitative study from June to October 2020 to assess the acceptability of participating in COVID-19 clinical trials among pregnant women in Spain. Phenomenology and grounded theory were used as methodological approaches. Semi-structured interviews were conducted with 24 pregnant women and six healthcare providers. Women were unsure if pregnancy was a risk factor to acquire the infection or to develop severe disease and expressed the limited information they had received, which led to uncertainties and emotional suffering. They had concerns regarding participation in clinical trials on COVID-19, regardless of the drug under study. Healthcare providers alluded to the importance of involving pregnant women's relatives at the recruitment visit of the clinical trial. These findings may be useful to facilitate pregnant women's participation in clinical trials.

Keywords: COVID-19; acceptability; clinical trial; healthcare professionals; perceptions; pregnancy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Pregnant women’s decision factors to participate in a clinical trial during pregnancy.

References

    1. van der Graaf R., van der Zande I.S., den Ruijter H.M., Oudijk M.A., van Delden J.J., Rengerink K.O., Groenwold R.H. Fair inclusion of pregnant women in clinical trials: An integrated scientific and ethical approach. Trials. 2018;19:78. doi: 10.1186/s13063-017-2402-9. - DOI - PMC - PubMed
    1. Whitehead C.L., Walker S.P. Consider pregnancy in COVID-19 therapeutic drug and vaccine trials. Lancet. 2020;395:e92. doi: 10.1016/S0140-6736(20)31029-1. - DOI - PMC - PubMed
    1. Payne P. Including Pregnant Women in Clinical Research: Practical Guidance for Institutional Review Boards. Ethic Hum. Res. 2019;41:35–40. doi: 10.1002/eahr.500036. - DOI - PubMed
    1. Heyrana K., Byers H.M., Stratton P. Increasing the Participation of Pregnant Women in Clinical Trials. JAMA. 2018;320:2077–2078. doi: 10.1001/jama.2018.17716. - DOI - PubMed
    1. Bischof E., Oertelt-Prigione S., Morgan R., Klein S.L., The Sex and Gender in COVID19 Clinical Trials Working Group (SGC) Gender and COVID19 Working Group Towards Precision Medicine: Inclusion of Sex and Gender Aspects in COVID-19 Clinical Studies—Acting Now before It Is Too Late—A Joint Call for Action. Int. J. Environ. Res. Public Health. 2020;17:3715. doi: 10.3390/ijerph17103715. - DOI - PMC - PubMed

Publication types